Center Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Center Laboratories has a total shareholder equity of NT$19.3B and total debt of NT$5.7B, which brings its debt-to-equity ratio to 29.6%. Its total assets and total liabilities are NT$26.0B and NT$6.7B respectively. Center Laboratories's EBIT is NT$199.6M making its interest coverage ratio 6.8. It has cash and short-term investments of NT$2.1B.
Key information
29.6%
Debt to equity ratio
NT$5.71b
Debt
| Interest coverage ratio | 6.8x |
| Cash | NT$2.14b |
| Equity | NT$19.28b |
| Total liabilities | NT$6.74b |
| Total assets | NT$26.03b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4123's short term assets (NT$3.8B) do not cover its short term liabilities (NT$4.0B).
Long Term Liabilities: 4123's short term assets (NT$3.8B) exceed its long term liabilities (NT$2.8B).
Debt to Equity History and Analysis
Debt Level: 4123's net debt to equity ratio (18.5%) is considered satisfactory.
Reducing Debt: 4123's debt to equity ratio has reduced from 33.3% to 29.6% over the past 5 years.
Debt Coverage: 4123's debt is not well covered by operating cash flow (4.5%).
Interest Coverage: 4123's interest payments on its debt are well covered by EBIT (6.8x coverage).